<ѻý>Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancerѻý> Decision on rucaparib follows negative OS signal and "discussions" with FDA Jun 17, 2022
<ѻý>FDA OKs Risankizumab for Crohn's Diseaseѻý> Approval marks the third indication for the IL-23 inhibitor in adults Jun 17, 2022
<ѻý>FDA Allows mRNA COVID Vaccines in Kids 6 Months and Upѻý> Vaccines expected to protect against most severe outcomes, says FDA Commissioner Jun 17, 2022
<ѻý>FDA Approves First Systemic Treatment for Alopecia Areataѻý> Four to 10 times as many patients met hair-regrowth endpoint with JAK inhibitor versus placebo Jun 13, 2022
<ѻý>FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kidsѻý> Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors Jun 10, 2022
<ѻý>It's High Noon for Dietary Supplementsѻý> The user fee legislation in Congress proposes useful regulations, but doesn't go far enough Jun 10, 2022
<ѻý>FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisibѻý> Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
<ѻý>Abbott Formula Plant Was 'Unacceptably Insanitary,' FDA Chief Tells Lawmakersѻý> Abbott official says the company is "deeply, deeply sorry" about the formula shortage May 26, 2022
<ѻý>FDA OKs First Novel Nonsteroidal Topical for Plaque Psoriasis in 25 Yearsѻý> Complete, near-complete clearance in 35-40% of patients treated with tapinarof cream 1% May 24, 2022
<ѻý>First Treatment Approved for Eosinophilic Esophagitisѻý> FDA expands dupilumab's label to treat inflammatory condition May 20, 2022
<ѻý>FDA Rejects Cheap Antidepressant to Treat Early COVIDѻý> David Boulware, who submitted the EUA for fluvoxamine, argues the agency is "behind the times" May 17, 2022
<ѻý>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetesѻý> Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<ѻý>Restrictions on Mifepristone a Barrier to Miscarriage Care, Surveys Showѻý> Over a third of respondents do not prescribe the drug for early pregnancy loss, despite efficacy May 10, 2022
<ѻý>Early Alzheimer's Test Gets FDA Nodѻý> First in vitro diagnostic to detect amyloid in early disease setting May 05, 2022
<ѻý>Two New Regimens Win FDA Approval for H. Pylori Infectionѻý> Dual and triple vonoprazan-based treatments offer physicians another set of options May 04, 2022
<ѻý>How Far Should the Menthol Ban Go?ѻý> It's time to ban menthol in cigarettes -- but not necessarily in all tobacco products May 02, 2022
<ѻý>FDA OKs New Nonstimulant Option for Adult ADHDѻý> New selective norepinephrine reuptake inhibitor is no longer just for kids May 02, 2022
<ѻý>FDA Proposes Ban on Menthol Cigarettesѻý> "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
<ѻý>FDA Approves First Drug for Recurrent Yeast Infectionsѻý> Vivjoa indicated for infertile or postmenopausal women Apr 28, 2022
<ѻý>FDA Issues Warning on Prenatal Genetic Testsѻý> Relying on results could lead to inappropriate medical decisions, agency warns Apr 19, 2022
<ѻý>First Topical Therapy for Facial Angiofibroma Nabs FDA Approvalѻý> New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
<ѻý>ALS Drug Needs More Evidence, FDA Advisors Sayѻý> But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
<ѻý>Another Oral Testosterone Undecanoate OK'd for Hypogonadismѻý> FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
<ѻý>Novel Fixed-Dose Immunotherapy Combo Wins FDA Approvalѻý> Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
<ѻý>Medicare Claws Back Money for Dubious Birth-Tissue Stem Cell Shotsѻý> Government seeks to recoup more than 2 years of payments for unproven treatments Mar 16, 2022
<ѻý>Meet the Primary Care Doc Who Wants the World to Go Back to Normalѻý> Lucy McBride, MD, has become a loud, controversial voice in the debate on COVID precautions Mar 15, 2022
<ѻý>First Generic OK'd for Popular Asthma, COPD Inhalerѻý> FDA approves Mylan's Symbicort copy, reflecting agency's commitment to "increase competition" Mar 15, 2022
<ѻý>FDA Warns on Using Surgical Device for Aesthetic Skin Proceduresѻý> Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
<ѻý>FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancerѻý> Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
<ѻý>FDA Begins Releasing Pfizer COVID Vax Documentsѻý> Court-ordered release runs risk of "cherry picking and taking things out of context" Mar 07, 2022
<ѻý>Dr. Bronner's Offering Its Workers Psychedelic Therapy Coverageѻý> Soap company to cover ketamine-assisted therapy for employees with new industry nonprofit Mar 01, 2022
<ѻý>Thumbs Down for IV Tramadol, FDA Advisers Sayѻý> Delayed onset of pain relief remains a concern Feb 16, 2022
<ѻý>FDA OKs 180-Day Implantable Continuous Glucose Monitorѻý> Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
<ѻý>FDA Warns of Strangulation Risk for Kids on Feeding Tubesѻý> Two toddlers died after being found with enteral feeding systems' tubing around their necks Feb 09, 2022
<ѻý>FDA Concerned About Safety of Lymphoma Drugѻý> Hint of excess mortality in trial of umbralisib/ublituximab prompts public notice Feb 03, 2022
<ѻý>FDA Approves First Generic of Restasis for Dry Eyeѻý> A new option for those affected by keratoconjunctivitis sicca Feb 02, 2022
<ѻý>Another COVID Vaccine Garners Full FDA Approvalѻý> Moderna's Spikevax approved for adults ages 18 and up Jan 31, 2022
<ѻý>Are We Equipped to Care for People With Intellectual, Developmental Disabilities?ѻý> Low accreditation standards are contributing to health disparities Jan 20, 2022
<ѻý>FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitisѻý> Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
<ѻý>Growing Controversy Over 'Skinny' Labeling for Generic Drugsѻý> What's at stake in legal battles over patent-avoiding approval pathway for generics Jan 17, 2022